Prevalence of alternative lengthening of telomeres in pediatric sarcomas determined by the telomeric DNA C-circle assay

  • 0Department of Pediatrics, Texas Tech University Health Sciences Center School of Medicine Cancer Center, Lubbock, TX, United States.

|

|

Summary

This summary is machine-generated.

Alternative lengthening of telomeres (ALT) was detected in 2.7% of rhabdomyosarcomas and 71% of osteosarcomas using the C-circle assay. This assay is a sensitive biomarker for ALT cancers, including sarcomas.

Area Of Science

  • Oncology
  • Molecular Biology
  • Genetics

Background

  • Alternative lengthening of telomeres (ALT) is a telomere maintenance mechanism observed in various cancers.
  • ALT cancers exhibit distinct patterns of therapy resistance and sensitivity.
  • Telomeric DNA C-circles are specific biomarkers for ALT cancers.

Purpose Of The Study

  • To determine the frequency of ALT in pediatric sarcomas, specifically Ewing's family sarcoma (EFS), rhabdomyosarcoma (RMS), and osteosarcoma (OS).
  • To evaluate the utility of the C-circle assay (CCA) for detecting ALT in these sarcoma subtypes.

Main Methods

  • DNA was extracted from fresh frozen primary tumor samples of EFS, RMS, and OS.
  • C-circles were enriched using isothermal rolling cycle amplification.
  • Real-time PCR was employed to detect and quantify C-circles, utilizing established cutoffs.

Main Results

  • Out of 94 EFS samples, 0 were C-circle positive (0% ALT).
  • Out of 187 RMS samples, 5 were C-circle positive (2.7% ALT).
  • Out of 87 OS samples, 62 were C-circle positive (71% ALT).

Conclusions

  • The C-circle assay (CCA) identified ALT in 2.7% of RMS and 71% of OS, with no ALT detected in EFS.
  • CCA is a robust and sensitive method for identifying ALT in sarcomas.
  • CCA holds potential as a companion diagnostic for targeted ALT therapeutics.